Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10032751HBVENSG00000011677.13protein_codingGABRA3NoNo2556P34903
TVIS20002957HPVENSG00000011677.13protein_codingGABRA3NoNo2556P34903
TVIS20031069HPVENSG00000011677.13protein_codingGABRA3NoNo2556P34903
TVIS20030899HPVENSG00000011677.13protein_codingGABRA3NoNo2556P34903
TVIS44021579HTLV-1ENSG00000011677.13protein_codingGABRA3NoNo2556P34903
TVIS44024241HTLV-1ENSG00000011677.13protein_codingGABRA3NoNo2556P34903
TVIS44014377HTLV-1ENSG00000011677.13protein_codingGABRA3NoNo2556P34903
TVIS44029002HTLV-1ENSG00000011677.13protein_codingGABRA3NoNo2556P34903
TCGA Plot Options
Drug Information
GeneGABRA3
DrugBank IDDB00402
Drug NameEszopiclone
Target IDBE0000523
UniProt IDP34903
Regulation Typeagonist
PubMed IDs19942638; 18973287
CitationsNutt DJ, Stahl SM: Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics. J Psychopharmacol. 2010 Nov;24(11):1601-12. doi: 10.1177/0269881109106927. Epub 2009 Nov 26.@@Hanson SM, Morlock EV, Satyshur KA, Czajkowski C: Structural requirements for eszopiclone and zolpidem binding to the gamma-aminobutyric acid type-A (GABAA) receptor are different. J Med Chem. 2008 Nov 27;51(22):7243-52. doi: 10.1021/jm800889m.
GroupsApproved; Investigational
Direct ClassificationCyclopyrrolones
SMILESCN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1
Pathways
PharmGKBPA162630444
ChEMBLCHEMBL1522